Funding
This research received no specific grant from any funding agency in the
public, commercial, or not-for-profit sectors”
References
- Molimard M, Raherison C, Lignot S,
et: Chronic
obstructive pulmonary disease exacerbation and inhaler device
handling: real-life assessment of 2935 patients. Eur Respir J.
2017, 49:1601794. doi: 10.1183/13993003.01794-2016.
- Sanchis J, Gich I, Pedersen
S: Systematic
review of errors in inhaler use: has patient technique improved over
time?. Chest . 2016, 150:394-406. doi:
10.1016/j.chest.2016.03.041..
- Hess DR. Aerosol delivery devices in the treatment of asthma.Respir Care . 2008, 53: 699-723.
- Hesselink AE, Penninx BW, Wijnhoven HA, Kriegsman DM, van Eijk JT.
Determinants of an incorrect inhalation technique in patients with
asthma or COPD. Scand J Prim Health Care . 2001;19(4):255-60.
doi: 10.1080/02813430152706792.
- Pedersen S, Frost L, Arnfred T. Errors in inhalation technique and
efficiency in inhaler use in asthmatic children. Allergy .
1986;41(2):118-24. doi: 10.1111/j.1398-9995.1986.tb00287.x.
- Goren A, Noviski N, Avital A, Maayan C, Stahl E, Godfrey S, Springer
C. Assessment of the ability of young children to use a powder inhaler
device (Turbuhaler). Pediatr Pulmonol. 1994;18(2):77-80. doi:
10.1002/ppul.1950180204.
- Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N.
Assessment of handling of inhaler devices in real life: an
observational study in 3811 patients in primary care. J Aerosol
Med . 2003;16(3):249-54. doi: 10.1089/089426803769017613.
- Connett GJ, Warde C, Wooler E, Lenny W: Use of budesonide in severe
asthmatic aged 1-3 years. Arch Dis Child . 1993; 69:351-355.
doi: 10.1136/adc.69.3.351.
- Luczak-Wozniak K, Dabrowska M, Domagala I, Miszczuk M, Lubanski W,
Leszczynski A, Krenke
R: Mishandling of
pMDI and DPI inhalers in asthma and COPD - repetitive and
non-repetitive errors. Pulm Pharmacol Ther . 2018; 51:65- 2.
doi: 10.1016/j.pupt.2018.06.002.
- Crane MA, Jenkins CR, Goeman DP, Douglass
JA: Inhaler device
technique can be improved in older adults through tailored education:
findings from a randomized controlled trial. NPJ Prim Care
Respir Med . 2014, 24:14034. doi: 10.1038/npjpcrm.2014.34.
- Hindle M, Chrystyn H. Determination of the relative of salbutamol to
the lung following inhalation. Br J Clin Pharmacol 1992; 34:
311–315. doi: 10.1111/j.1365-2125.1992.tb05921.x.
- Tomlinson HS, Corlett SA, Chrystyn H. Dose-response relationship and
reproducibility of urinary salbutamol excretion during the first 30
min after inhalation. Br J Clin Pharmacol. 2003; 56(2):225-7.
doi: 10.1046/j.1365-2125.2003.01864.x.
- Hindle M, Chrystyn H: Relative bioavailability of salbutamol to the
lung following inhalation using metered-dose inhalation methods and
spacer devices. Thorax . 1994, 49: 549-553. doi:
10.1136/thx.49.6.549.
- Hindle M, Newton DA, Chrystyn H. Investigations of an optimal inhaler
technique with the use of urinary salbutamol excretion as a measure of
relative bioavailability to the lung. Thorax . 1993
Jun;48(6):607-10. doi: 10.1136/thx.48.6.607.
- Du XL, Zhu Z, Fu Q, Li DK, Xu WB. Pharmacokinetics and relative
bioavailability of salbutamol metered-dose inhaler in healthy
volunteers. Acta Pharmacol Sin . 2002 Jul;23(7):663-6.
- Chege JK, Chrystyn H. Volumatic usage: some generic salbutamol
metered-dose inhalers can be used. Thorax 1994;49: 1162–1163.
doi: 10.1136/thx.49.11.1162.
- Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR. Et al.
Global Strategy for the Diagnosis, Management, and Prevention of
Chronic Obstructive Lung Disease: the GOLD science committee report
2019. Eur Respir J . 2019;53(5):1900164. doi:
10.1183/13993003.00164-2019.
- Ministry of Health. Vietnamese Guideline for Diagnosis and Treatment
of Chronic Obstructive Pulmonary Disease. 2015. (No 2866/QĐ-BYT).
Hanoi: Medical Publishing House; 2015.
- Sanchis J, Corrigan C, Levy ML, Viejo JL; ADMIT Group. Inhaler devices
– from theory to practice. Respir Med. 2013;107(4):495–502.
doi: 10.1016/j.rmed.2012.12.007.
- Batterink J, Dahri K, Aulakh A, Rempel C. Evaluation of the use of
inhaled medications by hospital inpatients with chronic obstructive
pulmonary disease. Can J Hosp Pharm . 2012;65(2):111–118. doi:
10.4212/cjhp.v65i2.1118.
- Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK. Evaluation of
a novel educational strategy, including inhaler-based reminder labels,
to improve asthma inhaler technique. Patient Educ Couns .
2008;72(1):26–33. doi: 10.1016/j.pec.2008.01.014.
- Lewis LD, McLaren M, Essex E, Cochrane GM. Plasma concentrations of
salbutamol in acute severe asthmatics. Aust N Z J Med .
1990;20(3):204-7. doi: 10.1111/j.1445-5994.1990.tb01019.x.
- Horn CR, Essex E, Hill P, Cochrane GM. Does urinary salbutamol reflect
compliance with the aerosol regimen in patients with asthma?Respir Med . 1989;83(1):15-8. doi:
10.1016/s0954-6111(89)80054-x.
- Silkstone VL, Corlett SA, Chrystyn H. Determination of the relative
bioavailability of salbutamol to the lungs and systemic circulation
following nebulization. Br J Clin Pharmacol. 2002
Aug;54(2):115-9. doi: 10.1046/j.1365-2125.2002.01632.x.
- Chege JK, Chrystyn H. The relative bioavailability of salbutamol to
the lung using urinary excretion following inhalation from a novel dry
powder inhaler: the effect of inhalation rate and formulation.Respir Med . 2000 Jan;94(1):51-6. doi: 10.1053/rmed.1999.0692.
- Al-Showair RA, Tarsin WY, Assi KH, Pearson SB, Chrystyn H. Can all
patients with COPD use the correct inhalation flow with all inhalers
and does training help? Respir Med . 2007;101:2395–401. doi:
10.1016/j.rmed.2007.06.008.
- Lavorini F, Magnan A, Christophe Dubus J, Voshaar T, Corbetta L,
Broeders M, Dekhuijzen R, Sanchis J, Viejo JL, Barnes P, et al. Effect
of incorrect use of dry powder inhalers on management of patients with
asthma and COPD. Respir Med. 2008;102:593–604. doi:
10.1016/j.rmed.2007.11.003.
- Göriş S, Taşci S, Elmali F. The effects of training on inhaler
technique and quality of life in patients with COPD. J Aerosol
Med Pulm Drug Deliv . 2013;26(6):336-44. doi: 10.1089/jamp.2012.1017.
- Sanchis J, Gich I, Pedersen S, Systematic review of errors in inhaler
use: has patient technique improved over
time? Chest. 2016; 150: 394–406. doi:
10.1016/j.chest.2016.03.041.
- Griffith MF, Feemster LC, Donovan LM, Spece LJ, Krishnan JA,
Lindenauer PK, McBurnie MA, Mularski RA, Au DH. Poor Metered-Dose
Inhaler Technique Is Associated with Overuse of Inhaled
Corticosteroids in Chronic Obstructive Pulmonary Disease. Ann Am
Thorac Soc . 2019;16(6):765-768. doi: 10.1513/AnnalsATS.201812-889RL.